Ali Zarrinpar

6.3k total citations · 2 hit papers
105 papers, 4.4k citations indexed

About

Ali Zarrinpar is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Ali Zarrinpar has authored 105 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Surgery, 50 papers in Hepatology and 29 papers in Epidemiology. Recurrent topics in Ali Zarrinpar's work include Organ Transplantation Techniques and Outcomes (40 papers), Liver Disease and Transplantation (36 papers) and Renal Transplantation Outcomes and Treatments (23 papers). Ali Zarrinpar is often cited by papers focused on Organ Transplantation Techniques and Outcomes (40 papers), Liver Disease and Transplantation (36 papers) and Renal Transplantation Outcomes and Treatments (23 papers). Ali Zarrinpar collaborates with scholars based in United States, Belgium and Lebanon. Ali Zarrinpar's co-authors include Wendell A. Lim, Ronald W. Busuttil, Jonathan R. Hiatt, Sanghyun Park, Roby P. Bhattacharyya, Vatche G. Agopian, Fady M. Kaldas, Douglas G. Farmer, Elizabeth Lancaster and Hasan Yersiz and has published in prestigious journals such as Nature, Science and Nature Medicine.

In The Last Decade

Ali Zarrinpar

98 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enabling Technologies for Personalized and Precision Medicine

2020 264 citations Ali Zarrinpar et al. profile →
Mechanisms of drug resistance in HCC

2023 197 citations Sergio Duarte, İlyas Şahin et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ali Zarrinpar United States	33	1.5k	1.5k	1.4k	1.0k	428	105	4.4k
Mamatha Bhat Canada	31	1.3k 0.9×	1.1k 0.7×	1.2k 0.8×	1.1k 1.1×	318 0.7×	173	3.6k
Toshimasa Asahara Japan	45	2.0k 1.3×	2.4k 1.6×	1.9k 1.3×	1.1k 1.1×	1.1k 2.7×	274	6.4k
Hartmut Schmidt Germany	46	1.1k 0.8×	3.8k 2.5×	1.7k 1.2×	1.6k 1.6×	1.2k 2.8×	360	9.2k
Uta Dahmen Germany	30	900 0.6×	637 0.4×	957 0.7×	1.0k 1.0×	215 0.5×	190	3.1k
Hong‐Shiee Lai Taiwan	42	909 0.6×	1.1k 0.8×	2.4k 1.7×	674 0.7×	1.4k 3.2×	266	5.6k
John Plevris United Kingdom	38	1.2k 0.8×	411 0.3×	2.0k 1.4×	1.1k 1.1×	363 0.8×	186	4.1k
Daniel Q. Huang Singapore	35	2.8k 1.8×	1.0k 0.7×	748 0.5×	4.8k 4.8×	591 1.4×	180	7.1k
Frank Dombrowski Germany	42	967 0.6×	2.8k 1.9×	1.4k 1.0×	1.2k 1.2×	1.0k 2.4×	157	5.9k
Christine Sempoux Belgium	52	2.7k 1.8×	1.8k 1.2×	4.4k 3.1×	2.8k 2.7×	2.6k 6.1×	314	9.9k
Syed A. Hussain United Kingdom	37	374 0.2×	1.4k 0.9×	2.4k 1.7×	502 0.5×	1.4k 3.4×	231	5.4k

Countries citing papers authored by Ali Zarrinpar

Since Specialization

Citations

This map shows the geographic impact of Ali Zarrinpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Zarrinpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Zarrinpar more than expected).

Fields of papers citing papers by Ali Zarrinpar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Zarrinpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Zarrinpar. The network helps show where Ali Zarrinpar may publish in the future.

Co-authorship network of co-authors of Ali Zarrinpar

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Zarrinpar. A scholar is included among the top collaborators of Ali Zarrinpar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Zarrinpar. Ali Zarrinpar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Muxuan, et al.. (2025). Artificial Intelligence in Oncology: A 10-Year ClinicalTrials.gov-Based Analysis Across the Cancer Control Continuum. Cancers. 17(21). 3537–3537.

Faria, Werviston De, et al.. (2025). Successful Liver Transplantation and Long-Term Survival in Patients with Perioperative Heparin-Induced Thrombocytopenia and Thromboembolic Complications. American Journal of Transplantation. 25(8). S460–S460.

Zarrinpar, Ali, et al.. (2024). Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature review. Liver Transplantation. 32(2). 283–295. 4 indexed citations

Huo, Zhiguang, Virginia Clark, Thiago Beduschi, et al.. (2024). Sirtuin3 promotes the degradation of hepatic Z alpha-1 antitrypsin through lipophagy. Hepatology Communications. 8(2). 2 indexed citations

Machado, Ana Carolina Dantas, Stephany Flores Ramos, Julia M. Gauglitz, et al.. (2023). Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry. Nature Communications. 14(1). 5303–5303. 10 indexed citations

Jansen, Caroline S., et al.. (2023). Physician–scientist trainees with parenting responsibilities need financial and childcare support. Nature Medicine. 29(12). 2990–2992. 2 indexed citations

Duarte, Sérgio Nascimento, et al.. (2023). Current Trends in Surgical Management of Hepatocellular Carcinoma. Cancers. 15(22). 5378–5378. 15 indexed citations

Özer, Muhammet, Rüveyda Ayasun, Jesus C. Fabregas, et al.. (2023). Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis. Journal of Hepatocellular Carcinoma. Volume 10. 1129–1141. 4 indexed citations

Moore, Helen, et al.. (2023). Quantitative methods for optimizing patient outcomes in liver transplantation. Liver Transplantation. 30(3). 311–320. 3 indexed citations

10.

Duarte, Sergio, et al.. (2023). Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden. Journal of the American College of Surgeons. 238(4). 770–778. 11 indexed citations

11.

Gulbahce, Natali, et al.. (2021). High levels of donor-derived cell-free DNA in a case of graft-versus-host-disease following liver transplantation. American Journal of Transplantation. 22(3). 973–976. 10 indexed citations

12.

Sosa, Rebecca A., Fady M. Kaldas, Yiping Jin, et al.. (2020). Disulfide High‐Mobility Group Box 1 Drives Ischemia‐Reperfusion Injury in Human Liver Transplantation. Hepatology. 73(3). 1158–1175. 51 indexed citations

13.

Schaub, Franz X., et al.. (2020). Tumor-Derived Organoid Culture For Functional Personalized Oncology In Cholangiocarcinoma. HPB. 22. S26–S27. 1 indexed citations

14.

Kageyama, Shoichi, Kojiro Nakamura, Takehiro Fujii, et al.. (2018). Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor. Hepatology. 68(1). 258–273. 43 indexed citations

15.

Palumbo, Tiziana, Kojiro Nakamura, Charles Lassman, et al.. (2016). Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model. Transplantation. 101(2). 322–331. 27 indexed citations

16.

DiNorcia, Joseph, Minna K. Lee, Michael P. Harlander‐Locke, et al.. (2015). Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant. JAMA Surgery. 150(11). 1066–1066. 20 indexed citations

17.

Buzzanco, Anthony S., Angela C. Gomez, B.A. French, et al.. (2014). Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections. Experimental and Molecular Pathology. 97(3). 399–410. 6 indexed citations

18.

Agopian, Vatche G., Michael P. Harlander‐Locke, Ali Zarrinpar, et al.. (2014). A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients. Journal of the American College of Surgeons. 220(4). 416–427. 188 indexed citations

19.

Zarrinpar, Ali & Johnny C. Hong. (2012). What is the Prognosis After Retransplantation of the Liver?. Advances in Surgery. 46(1). 87–100. 23 indexed citations

20.

Zarrinpar, Ali, Douglas G. Farmer, R. Mark Ghobrial, et al.. (2007). Liver Transplantation for HELLP Syndrome. The American Surgeon. 73(10). 1013–1016. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact